| Participant Name |
Role: Co-Chair/ CE Presenter / Moderator / Peer Reviewer |
Financial Disclosure for 24 Months (relationship is ongoing) |
| Adeyemo, Adebowale |
GIM Open Editor |
Pending |
| AlKuraya, Fowzan |
GIM Editor |
SAB: Neutrolis, Inc. Employee: Lifera Omerics |
| Bennet, Robin |
GIM Editor |
No Relevant Financial Relationship |
| Bombard, Yvonne |
GIM Open Editor |
Pending |
| Brunetti-Pierri, Nicola |
GIM Open Editor |
No Relevant Financial Relationship |
| Choy, Richard |
GIM Open Editor |
Pending |
| Couser, Natario |
GIM Open Editor |
No Relevant Financial Relationship |
| Cox, Allison |
GIM Editor |
No Relevant Financial Relationship |
| Dhar, Shweta |
GIM Editor |
No Relevant Financial Relationship |
| Drexler, Diane Dunham |
GIM Editor |
No Relevant Financial Relationship |
| Duque-Lasio, Maria Laura |
GIM Editor |
No Relevant Financial Relationship |
| Freeman, Peter |
GIM Open Editor |
No Relevant Financial Relationship |
| Freeman, Peter |
GIM Editor |
No Relevant Financial Relationship |
| Gambello, Michael |
GIM Editor |
No Relevant Financial Relationship |
| Goddard, Katrina |
GIM Editor |
No Relevant Financial Relationship |
| Hisama, Fuki |
GIM Open Editor |
DSMB: Larimar Therapeutics |
| Koeberl, Dwight |
GIM Editor |
Consultant: AskBio, Bayer Pharmaceuticals DSB: Baxalta, Takeda Pharmaceuticals Patent: Bayer Pharmaceuticals |
| Kozel, Beth |
GIM Editor |
No Relevant Financial Relationship |
| Lazaro-Munoz, Gabriel |
GIM Editor |
No Relevant Financial Relationship |
| Lansdon, Lisa |
GIM Editor |
No Relevant Financial Relationship |
| Lebo, Matthew |
GIM Open Editor |
No Relevant Financial Relationship |
| Levy-Lahad, Ephrat |
GIM Editor |
No Relevant Financial Relationship |
| Li, Hong |
GIM Open Editor |
pending |
| Li, Marilyn |
GIM Open Editor |
No Relevant Financial Relationship |
| Lu, Qiongshi |
GIM Open Editor |
No Relevant Financial Relationship |
| Miller, David |
GIM Editor |
Stock: Vertex Pharmaceuticals Inc. |
| Mori, Mari |
GIM Editor |
No Relevant Financial Relationship |
| Mvundura, Mercy |
GIM Editor |
No Relevant Financial Relationship |
| Nathanson, Kate |
GIM Editor |
No Relevant Financial Relationship |
| Ormond, Kelly |
GIM Open Editor |
No Relevant Financial Relationship |
| Pereira, Stacey |
GIM Editor |
No Relevant Financial Relationship |
| Porath, Binu |
GIM Editor |
Employee: Labcorp |
| Rahm, Alanna |
GIM Editor |
pending |
| Rasmussen, Sonja |
GIM Editor |
pending |
| Rehder, Catherine |
GIM Editor |
Consultant: Alexion Pharmaceuticals, Amicus Therapeutics, Inc. |
| Riggs, Erin |
GIM Open Editor |
Consultant: Illumina, Inc., Mirum Pharmaceuticals |
| Rose, Nancy |
GIM Editor |
Consultant: BillionToOne, Inc. |
| Schrodi, Steve |
GIM Editor |
Patents: Celera Corporation |
| Scott, Stuart |
GIM Open Editor |
No Relevant Financial Relationship |
| Shankar, Suma |
GIM Editor |
No Relevant Financial Relationship |
| Smith, Hadley |
GIM Editor |
Consultant: Illumina, Inc. |
| Steiner, Robert |
GIM Editor |
Consultant: Exact Sciences, Mirum Pharma; PTC Therapeutics, Ultragenyx Pharmaceuticals Travel support: Astellas Patents: in newborn screening |
| Stevenson, Dave |
GIM Editor |
Consultant: BioMarin; Novartis |
| Stewart, Douglas |
GIM Editor |
No Relevant Financial Relationship |
| Sutton, V.Reid |
GIM Editor |
Stock: Aceragen Speaker’s Bureau: Abbott Nutrition Consultant: Applied Therapeutics; Biomarin Pharmaceuticals; QED Therapeutics Grant: Ultragenyx Pharmaceutical, Inc. |
| Tan, Wen-Hann |
GIM Open Editor |
Consultant: Baker Co.; Coactuate: Denali Therapeutics Inc. Research: F. Hoffman LaRoche Ltd.; Ionis Pharmaceuticals; Ultragenyx Pharmaceuticals |
| Tarczy-Hornoch, Peter |
GIM Editor |
No Relevant Financial Relationship |
| Webb, Bryn |
GIM Editor |
No Relevant Financial Relationship |
| Wu, Ryanne |
GIM Editor |
Employee: 23andMe Consultant: MeTree&You |
| Wu, Nan |
GIM Open Editor |
Grant: Illumina |
| Yin, Xianyong |
GIM Editor |
No Relevant Financial Relationship |
| Yuan, Bo |
GIM Open Editor |
Itellectual Property: UptoDate |